BioPlus Acquisition Corp. announced the pricing of its upsized $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BIOSU” Friday, December 3.
The new SPAC intends to combine with a global life sciences business with strong preclinical or clinical data driving confidence in successful clinical proof of concept. BioPlus is led by Chairman and Chief Business Officer Jonathan Rigby, CEO and CFO Ross Haghighat, and Vice Chairman designee Ronald Eastman.
Total SPAC deal count for 2021 year-to-date is now 570. This offering is expected to close on Tuesday, December 7.
Cantor Fitzgerald & Co. is acting as the sole book running manager for the offering. Latham & Watkins LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. WithumSmith+Brown,PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...